Seraphina Therapeutics
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $11M
Investors
- 4
About Seraphina Therapeutics
Seraphina Therapeutics Inc.Founded in 2017 and headquartered in San Diego, US, Seraphina Therapeutics Inc. specializes in nutritional health products. The company was co-founded by Eric Venn-Watson and Stephanie Venn-Watson, the latter also serves as the CEO.Seraphina Therapeutics specializes in developing consumer health products centered around key fatty acids. Its flagship product, C15:0 (pentadecanoic acid), is derived from natural sources such as butter and certain fish, aimed at improving health outcomes by replenishing essential micronutrients.Seraphina Therapeutics generates revenue through direct-to-consumer sales and partnerships with health and wellness retailers, primarily through its flagship product, C15:0. The company aims to broaden its product offerings and develop new health solutions, while also exploring expansion into additional geographical markets to meet rising consumer demand.
Who invested in Seraphina Therapeutics
4 investors across 2 rounds
See all investors in Seraphina Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Seraphina Therapeutics
Who invested in Seraphina Therapeutics?
Seraphina Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Seraphina Therapeutics raised?
Seraphina Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Seraphina Therapeutics last raise money?
Seraphina Therapeutics's most recent round on record is a Series A, in Oct 2021.
What does Seraphina Therapeutics do?
Seraphina Therapeutics is a biotechnology company.
Where is Seraphina Therapeutics headquartered?
Seraphina Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Seraphina Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Seraphina Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Seraphina Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.